Theralase Technologies Inc. V.TLT

Other Indications Impressive Preclinical Data

[enriquesuave]

Colorectal preclinical subcutaneous mouse model Rutherin + X-Rays  Vs X-Rays alone.  

Tumor volume after 45 days
Rutherin : 30mm cube. Vs 330mm cube. Thus 90% improvement vs radiation alone

Rutherin survival at 70 days 63% vs 23% for radiation alone 

Excellent improvement for GBM and NSCLC as well. It's in the MD&A on Sedar.  

Enough cash for another 12 months as per report.  Hopefully good data and SP increase before and/or  BTD.

[CancerSlayer]

  In the MD&A, TLT mentions the use of radiotherapy (RT), but they don't specify the type of RT they plan to use in their future GBM & NSCLC studies.  I'm assuming external/x-ray.  However, all of the following RT options are available:  1) only external 2) only internal/intraoperative RT or 3) a combination of the two.   Based on the various models